U.S. healthcare giant Pfizer has agreed to invest 90.5 million euros ($95.24 million) to buy an 8.1% percent stake in French vaccines company , as the companies announced developments in their partnership to tackle the Lyme disease.
Pfizer will buy the stake in Valneva, which is also working on its COVID-19 vaccine, at a price of 9.49 euros per share, via a reserved capital increase.Register now for FREE unlimited access to Reuters.comValneva will use the proceeds from Pfizer’s equity investment to support its Phase 3 development contribution to the Lyme disease program.
"Pfizer's investment in Valneva highlights the quality of the work that we’ve done together over the past two years and is a strong recognition of Valneva's vaccine expertise," said Valneva chief executive Thomas Lingelbach.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
CDC recommends Pfizer, Moderna Covid-19 vaccine for babies and toddlersShots will be be available for children from 6 months to 5 years as early as next week.
Weiterlesen »
COVID vaccine: US opens Pfizer, Moderna shots for kids under 5The CDC s unanimously decided that COVID-19 vaccines should be opened to kids under 5 years of age.
Weiterlesen »
CDC advisers recommend Pfizer, Moderna COVID shots for kids under 5The CDC s unanimously decided that COVID-19 vaccines should be opened to kids under 5 years of age.
Weiterlesen »
CDC advisers recommend Pfizer, Moderna COVID shots for kids under 5The CDC recommended COVID-19 vaccines for infants, toddlers and preschoolers on Saturday.
Weiterlesen »
COVID vaccine: US opens Pfizer, Moderna shots for kids under 5The CDC recommended COVID-19 vaccines for infants, toddlers and preschoolers on Saturday.
Weiterlesen »
COVID vaccine: US opens Pfizer, Moderna shots for kids under 5The CDC recommended COVID-19 vaccines for infants, toddlers and preschoolers on Saturday.
Weiterlesen »